U.S. flag

An official website of the United States government

NM_000059.4(BRCA2):c.68-9T>G AND Familial cancer of breast

Germline classification:
not provided (1 submission)
Review status:
no classification provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000577751.2

Allele description [Variation Report for NM_000059.4(BRCA2):c.68-9T>G]

NM_000059.4(BRCA2):c.68-9T>G

Gene:
BRCA2:BRCA2 DNA repair associated [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q13.1
Genomic location:
Preferred name:
NM_000059.4(BRCA2):c.68-9T>G
HGVS:
  • NC_000013.11:g.32319068T>G
  • NG_012772.3:g.8589T>G
  • NG_017006.2:g.1296A>C
  • NM_000059.4:c.68-9T>GMANE SELECT
  • LRG_293t1:c.68-9T>G
  • LRG_293:g.8589T>G
  • NC_000013.10:g.32893205T>G
  • NM_000059.3:c.68-9T>G
Links:
dbSNP: rs397507883
NCBI 1000 Genomes Browser:
rs397507883
Molecular consequence:
  • NM_000059.4:c.68-9T>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:
Familial cancer of breast
Synonyms:
Breast cancer, familial; Hereditary breast cancer
Identifiers:
MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000678803ClinVar Staff, National Center for Biotechnology Information (NCBI)
no classification provided
not providedgermlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Evaluation of the diagnostic accuracy of the stop codon (SC) assay for identifying protein-truncating mutations in the BRCA1and BRCA2genes in familial breast cancer.

Sakayori M, Kawahara M, Shiraishi K, Nomizu T, Shimada A, Kudo T, Abe R, Ohuchi N, Takenoshita S, Kanamaru R, Ishioka C.

J Hum Genet. 2003;48(3):130-7.

PubMed [citation]
PMID:
12624724

Details of each submission

From ClinVar Staff, National Center for Biotechnology Information (NCBI), SCV000678803.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 8, 2024